Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2008

01-12-2008 | Preface

Proposal of podocytic infolding glomerulopathy as a new disease entity

Authors: Kensuke Joh, Hirofumi Makino

Published in: Clinical and Experimental Nephrology | Issue 6/2008

Login to get access

Excerpt

In recent case presentations at conferences in Japan and in personal consultations, we had begun to recognize a rare and peculiar glomerulopathy, in which microspheres and microtubular structures are shown in the glomerular basement membrane (GBM) in association with infolding of cytoplasmic processes of podocytes into the GBM. This rare and peculiar glomerulopathy has not yet been included in the World Health Organization’s classification of glomerular diseases, and only a few case reports have been published in the literature. We had no idea whether this lesion indicated a new disease entity or a transient morphological finding of a well-known disease. It was necessary to discern a clearer clinical and pathological profile and an effective treatment. However, it was difficult to accumulate cases at a single institution, because this glomerulopathy is extremely rare. Therefore, the Japanese Society of Nephrology has established a research working group and has collected cases from all over Japan in an attempt to understand the complete spectrum of this glomerulopathy. …
Metadata
Title
Proposal of podocytic infolding glomerulopathy as a new disease entity
Authors
Kensuke Joh
Hirofumi Makino
Publication date
01-12-2008
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2008
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0105-y

Other articles of this Issue 6/2008

Clinical and Experimental Nephrology 6/2008 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.